Nuzzolese, Imperia
Cavalieri, Stefano
Licitra, Lisa F
Alfieri, Salvatore
Article History
Accepted: 30 May 2025
First Online: 9 July 2025
Declarations
:
: Not required.
: Not required.
: Not required.
: o Imperia Nuzzolese and Salvatore Alfieri declare no conflicts of interest.o Lisa Licitra declares the following conflicts of interest: Consulting fees: MSD IT; Merck Serono Spa Healtcare Professional; Merck Healtcare KGaA; GSK, F. Hoffman La Roche Ltd; EMD Serono Research & Development Institute, Inc.; Boehringer Ingelhem International GmbH; Simon-Kucher & Partners Strategy & Marketing Consultants; Rgenta Therapeutics, Inc; Alentis Therapeutics AG; MedImmune Limited. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Merck Serono Spa; MSD IT; Merck Healtcare KGaA; Adlai Nortye; Bristol Mayers Squibb [K.K.]; ALTIS Omnia Pharma Service Srl. Support for attending meetings and/or travel: TAE Life Science. Participation on a Data Safety Monitoring Board or Advisory Board: Merck Healtcare KGaA.; Merck & Co. Inc; a; MSD IT; EMD Serono Research & Development Institute, Inc.; F. Hoffman-La Roche Ltd; Janssen Research & Development, LLC; Seagen International GmbH; Genmab US, Inc.; Astrazeneca UK limited; Abbvie Srl; Simon-Kucher & Partners Strategy & Marketing Consultants; Purple Biotech, Ltd. Grants or contracts from any entity. Research funds donated directly to the institution for clinical trials I have participated: Adlai Nortye; Astrazeneca; BMS; Debiopharm International SA; Eisai; Eli Lilly and Company; Exelixis; Hoffman-La Roche Ltd; Isa Therapeutics; Kura Oncology; Merck Serono; MSD; Merck Sharp&Dome Corp; Nektar Therapeutics; Novartis; Regeneron; Roche; Sanofi; Syneos; Sun Pharmaceutica; Incyte Biosciences International Sàrl; Gilead Sciences, Inc.; Genmab; Merck Healthcare KgaA.o Stefano Cavalieri declares occasional fees for participation as a speaker at conferences/congresses from AccMed; support for attending meetings and/or travel from AccMed, MultiMed Engineers srl, Care Insight sas, unrelated to the content of this work.